Coexpression of avian influenza virus H5 and N1 by recombinant newcastle disease virus and the impact on immune response in chickens

Avian Diseases

Volumn 55, Issue 3, 2011, Pages 413-421

  Ramp, Kristina ^a   Veits, Jutta ^a   Deckers, Daniela ^a   Rudolf, Miriam ^a   Grund, Christian ^a   Mettenleiter, Thomas C ^a   Römer Oberdörfer, Angela ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

HPAIV; NDV; vaccine, H5

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NA PROTEIN, INFLUENZA A VIRUS; SIALIDASE; VIRUS PROTEIN;

ANIMAL; ARTICLE; AVIAN INFLUENZA; CHICKEN; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; NEWCASTLE DISEASE PARAMYXOVIRUS; PATHOGENICITY; VIRUS SHEDDING;

ANIMALS; CHICKENS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; NEURAMINIDASE; NEWCASTLE DISEASE VIRUS; VIRAL PROTEINS; VIRUS SHEDDING;

ANIMALIA; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 80053241658     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9652-011111-Reg.1     Document Type: Article

References (32)

1. Buchholz, U. J., S. Finke, and K. K. Conzelmann. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259. 1999. (Pubitemid 28565367)
2. Calain, P., and L. Roux. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:4822-4830. 1993. (Pubitemid 23215963)
3. Capua, I., and D. J. Alexander. Avian influenza: Recent developments. Avian Pathol. 33:393-404. 2004. (Pubitemid 39290206)
4. Capua, I., and D. J. Alexander. Animal and human health implications of avian influenza infections. Biosci. Rep. 27:359-372. 2007. (Pubitemid 350163716)
5. [CEC] Council of the European Communities. Council Directive 92/66/EEC introducing Community measures for the control of Newcastle disease. Official Journal of the European Community L 260:1-20. 1992.
6. CEC. Council Directive 92/40/EEC introducing Community measures for the control of avian influenza. Official Journal of the European Communities L 167:1-16. 1992.
7. Chen, W., P. A. Calvo, D. Malide, J. Gibbs, U. Schubert, I. Bacik, S. Basta, R. O'Neill, J. Schickli, P. Palese, P. Henklein, J. R. Bennink, and J. W. Yewdell. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:1306-1312. 2001. (Pubitemid 34007934)
8. DiNapoli, J. M., B. Nayak, L. Yang, B. W. Finneyfrock, A. Cook, H. Andersen, F. Torres-Velez, B. R. Murphy, S. K. Samal, P. L. Collins, and A. Bukreyev. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J. Virol. 84:1489-503. 2010.
9. Fauquet, C. M., and M. A. Mayo. Paramyxoviridae. In: 8th Report of the International Committee on the Taxonomy of Viruses. C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball, eds. Elsevier Academic Press, San Diego, London, England. pp. 655-671. 2005.
10. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79:2814-2822. 2005. (Pubitemid 40270559)
11. Fuchs, W., A. Römer-Oberdörfer, J. Veits, and T. C. Mettenleiter. Novel avian influenza virus vaccines. Rev. Sci. Tech. 28:319-332. 2009.
12. Ge, J., G. Deng, Z. Wen, G. Tian, Y. Wang, J. Shi, X. Wang, Y. Li, S. Hu, Y. Jiang, C. Yang, K. Yu, Z. Bu, and H. Chen. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81:150-158. 2007. (Pubitemid 44975155)
13. Gohrbandt, S., J. Veits, J. Hundt, J. Bogs, A. Breithaupt, J. P. Teifke, S. Weber, T. C. Mettenleiter, and J. Stech. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5. J. Gen. Virol. 92:51-59. 2011.
14. Horimoto, T., and Y. Kawaoka. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J. Virol. 68:3120-3128. 1994. (Pubitemid 24129761)
15. Johansson, B. E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17:2073-2080. 1999. (Pubitemid 29172380)
16. Kalthoff, D., A. Breithaupt, J. P. Teifke, A. Globig, T. Harder, T. C. Mettenleiter, and M. Beer. Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg. Infect. Dis. 14:1267-1270. 2008.
17. Nakaya, T., J. Cros, M. S. Park, Y. Nakaya, H. Zheng, A. Sagrera, E. Villar, A. Garcia-Sastre, and P. Palese. Recombinant Newcastle disease virus as a vaccine vector. J. Virol. 75:11,868-11,873. 2001. (Pubitemid 33063278)
18. Nayak, B., S. Kumar, J. M. DiNapoli, A. Paldurai, D. R. Perez, P. L. Collins, and S. K. Samal. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J. Virol. 84:2408-2420. 2010.
19. Palese, P., and M. S. Shaila. Orthomyxoviridae virus and their replication. In: Fields virology, 5th. ed. D. M. Knipe and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia. pp. 1647-1689. 2007.
20. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208. 2006. (Pubitemid 43801076)
21. Pavlova, S. P., J. Veits, T. C. Mettenleiter, and W. Fuchs. Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype. Vaccine 27:5085-5090. 2009.
22. Peeters, B. P., Y. K. Gruijthuijsen, O. S. de Leeuw, and A. L. Gielkens. Genome replication of Newcastle disease virus: Involvement of the rule-of-six. Arch. Virol. 145:1829-1845. 2000.
23. Qiao, C. L., K. Z. Yu, Y. P. Jiang, Y. Q. Jia, G. B. Tian, M. Liu, G. H. Deng, X. R. Wang, Q. W. Meng, and X. Y. Tang. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32:25-32. 2003.
24. Römer-Oberdörfer, A., E. Mundt, T. Mebatsion, U. J. Buchholz, and T. C. Mettenleiter. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J. Gen. Virol. 80:2987-2995. 1999. (Pubitemid 29504672)
25. Römer-Oberdörfer, A., J. Veits, D. Helferich, and T. C. Mettenleiter. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26:2307-2313. 2008.
26. Schröer, D., J. Veits, C. Grund, M. Dauber, G. Keil, H. Granzow, T. C. Mettenleiter, and A. Römer-Oberdörfer. Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis. 53:190-197. 2009.
27. Spackman, E., D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber, M. L. Perdue, K. Lohman, L. T. Daum, and D. L. Suarez. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40:3256-3260. 2002. (Pubitemid 34977437)
28. Steinhauer, D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20. 1999. (Pubitemid 29391776)
29. Steward, M., I. B. Vipond, N. S. Millar, and P. T. Emmerson. RNA editing in Newcastle disease virus. J. Gen. Virol. 74:2539-2547. 1993. (Pubitemid 24020645)
30. Veits, J., D. Wiesner, W. Fuchs, B. Hoffmann, H. Granzow, E. Starick, E. Mundt, H. Schirrmeier, T. Mebatsion, T. C. Mettenleiter, and A. Römer-Oberdörfer. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc. Natl. Acad. Sci. U. S. A. 103:8197-8202. 2006. (Pubitemid 43801075)
31. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179. 1992.
32. [WHO] World Health Organization. Avian influenza [Internet]. World Health Organization, Geneva, Switzerland. 2011 [modified 2011 Apr XX; cited 2011 Apr XX]. Available from: Http://www.who.int/csr/disease/avian-influenza/country/en